These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9734314)

  • 1. Synthesis and muscarinic activity of a series of quinolines and naphthalenes with a 1-azabicyclo[3.3.0]octane moiety.
    Suzuki T; Usui T; Oka M; Suzuki T; Kataoka T
    Chem Pharm Bull (Tokyo); 1998 Aug; 46(8):1265-73. PubMed ID: 9734314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and muscarinic activity of novel aniline derivatives with a 1-azabicyclo[3.3.0]octane moiety.
    Suzuki T; Oka M; Maeda K; Furusawa K; Uesaka H; Kataoka T
    Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):28-36. PubMed ID: 9987823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of (1-azabicyclo[3.3.0]octanyl)methyl-substituted aromatic heterocycles and their muscarinic activity.
    Suzuki T; Uesaka H; Hamajima H; Ikami T
    Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):876-9. PubMed ID: 10399839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity studies of a series of 1-oxa-2,8-diazaspiro[4.5]decan-3-ones and related compounds as M1 muscarinic agonists.
    Tsukamoto S; Nagaoka H; Igarashi S; Wanibuchi F; Hidaka K; Tamura T
    Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1523-9. PubMed ID: 7586076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane .
    Bymaster FP; Shannon HE; Rasmussen K; Delapp NW; Mitch CH; Ward JS; Calligaro DO; Ludvigsen TS; Sheardown MJ; Olesen PH; Swedberg MD; Sauerberg P; Fink-Jensen A
    Eur J Pharmacol; 1998 Sep; 356(2-3):109-19. PubMed ID: 9774240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity studies of a series of 1-oxa-8-azaspiro[4.5]decanes as M1 muscarinic agonists.
    Tsukamoto S; Fujii M; Yasunaga T; Matsuda K; Wanibuchi F; Hidaka K; Furuya T; Tamura T
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):842-52. PubMed ID: 7553970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of the metabolites of N-[2-(1-azabicyclo[3.3.0]octan-5-yl)ethyl]-2-nitroaniline fumarate (SK-946).
    Suzuki T; Inagaki H; Hamajima H; Uesaka H; Hori K; Ikami T
    Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):880-3. PubMed ID: 10399840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of new cardioselective M2 muscarinic receptor antagonists.
    Mandelli GR; Maiorana S; Terni P; Lamperti G; Colibretti ML; Imbimbo BP
    Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1611-22. PubMed ID: 11086886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives.
    Jeppesen L; Olesen PH; Hansen L; Sheardown MJ; Thomsen C; Rasmussen T; Jensen AF; Christensen MS; Rimvall K; Ward JS; Whitesitt C; Calligaro DO; Bymaster FP; Delapp NW; Felder CC; Shannon HE; Sauerberg P
    J Med Chem; 1999 Jun; 42(11):1999-2006. PubMed ID: 10354408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological activity, and quantitative structure-activity relationship study of azanaphthalimide and arylnaphthalimide derivatives.
    Braña MF; Gradillas A; Gómez A; Acero N; Llinares F; Muñoz-Mingarro D; Abradelo C; Rey-Stolle F; Yuste M; Campos J; Gallo MA; Espinosa A
    J Med Chem; 2004 Apr; 47(9):2236-42. PubMed ID: 15084122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of a new potent anticholinesterasic compound (+/-)huprine X with muscarinic receptors in rat brain.
    Roman S; Vivas NM; Badia A; Clos MV
    Neurosci Lett; 2002 Jun; 325(2):103-6. PubMed ID: 12044632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
    Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
    J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
    Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and cholinergic properties of bis[[(dimethylamino)methyl]furanyl] analogues of ranitidine.
    Sowell JW; Tang Y; Valli MJ; Chapman JM; Usher LA; Vaughan CM; Kosh JW
    J Med Chem; 1992 Mar; 35(6):1102-8. PubMed ID: 1552502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
    Pei XF; Gupta TH; Badio B; Padgett WL; Daly JW
    J Med Chem; 1998 Jun; 41(12):2047-55. PubMed ID: 9622546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
    J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis and pharmacological activity of 1,2,3-triazole derivatives of naphthalene, quinoline and pyridine].
    Livi O; Ferrarini PL; Tonetti I; Smaldone F; Zefola G
    Farmaco Sci; 1979 Mar; 34(3):217-28. PubMed ID: 230987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
    Arnt J; Lembøl HL; Meier E; Pedersen H
    Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonists.
    Triggle DJ; Kwon YW; Abraham P; Rahman MA; Carroll FI
    Pharm Res; 1992 Nov; 9(11):1474-9. PubMed ID: 1475236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzylidene ketal derivatives as M2 muscarinic receptor antagonists.
    Boyle CD; Chackalamannil S; Chen LY; Dugar S; Pushpavanam P; Billard W; Binch H; Crosby G; Cohen-Williams M; Coffin VL; Duffy RA; Ruperto V; Lachowicz JE
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2727-30. PubMed ID: 11133078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.